Core Insights - Investors are showing a bullish stance on Tempus AI (NASDAQ:TEM), with significant options trading activity indicating potential upcoming developments [1][2] - The overall sentiment among large investors is split evenly between bullish and bearish positions, with a notable preference for call options [2] - Analysts have set an average target price of $80.0 for Tempus AI, reflecting positive market expectations [9][10] Options Trading Activity - A total of 13 uncommon options trades were identified for Tempus AI, with 11 call options amounting to $963,056 and 2 put options totaling $85,500 [1][2] - The projected price window for Tempus AI based on recent options activity is between $50.0 and $70.0 [3] - Detailed analysis of volume and open interest indicates strong investor interest in options with strike prices from $50.0 to $70.0 over the past 30 days [4][5] Company Overview - Tempus AI Inc is a technology company focused on healthcare data, utilizing AI to enhance the accuracy and personalization of laboratory tests [8] - The company is currently trading at $64.45, reflecting a 3.35% increase, with a trading volume of 3,670,308 [11]

Deep-pocketed investors have adopted a bearish approach towards Tempus AI (NASDAQ:TEM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TEM usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Tempus AI. ...

Group 1: Market Sentiment and Trading Activity - Financial giants have shown a bullish sentiment towards Tempus AI, with 45% of traders being bullish and 27% bearish, indicating a strong interest in the stock [1] - The options trading history revealed 48 unusual trades, with a total value of $4,022,345 in calls and $86,550 in puts [1] - Major market movers are focusing on a price range between $65.0 and $135.0 for Tempus AI over the last three months [2] Group 2: Volume and Open Interest - The average open interest for Tempus AI options is 3,091.96, with a total trading volume of 12,855.00 [3] - A detailed chart illustrates the trends in call and put option volume and open interest for high-value trades within the strike price corridor of $65.0 to $135.0 over the past 30 days [3] Group 3: Company Overview - Tempus AI Inc is a technology company that has developed the Tempus Platform, which aims to integrate healthcare data and enhance the accuracy of laboratory tests using AI [10] - The company is currently rated by two market experts, with a consensus target price of $96.5 [12] Group 4: Analyst Ratings - Analysts from HC Wainwright & Co. and Guggenheim maintain a Buy rating on Tempus AI, with target prices of $98 and $95 respectively [13] Group 5: Current Stock Performance - The stock price of Tempus AI (TEM) is currently at $93.0, reflecting a 4.14% increase, with a trading volume of 4,666,125 [15]

Group 1: Market Sentiment and Trading Activity - Financial giants have shown a bearish sentiment towards Tempus AI, with 50% of traders exhibiting bearish tendencies and 44% bullish [1] - A total of 34 unusual trades were identified, with 13 puts valued at $579,742 and 21 calls valued at $1,109,663 [1] - Significant options trades include a bullish call sweep with a total trade price of $196.6K at a strike price of $115.00 and a bearish call trade at a strike price of $20.00 valued at $81.9K [9] Group 2: Price Target and Market Analysis - Major market movers are focusing on a price band between $20.0 and $115.0 for Tempus AI over the last three months [2] - The consensus target price for Tempus AI is $94.0, with one analyst adjusting the price target to $90 and another maintaining a target of $98 [11][12] - The current trading volume for Tempus AI is 5,862,539, with the stock price down by -2.92% to $76.92 [14] Group 3: Company Overview - Tempus AI Inc is a technology company that has developed the Tempus Platform, which aims to integrate healthcare data and enhance laboratory test accuracy using AI [10]